Clin2
NCT07572370Likely a fitRecruiting

Reducing Follow-up Visits After Breast Cancer Treatment

Breast Cancer

Part of Cancer, Skin clinical trials.

This study tests whether patients who have finished breast cancer treatment and are doing well can safely have fewer doctor visits and scans. Researchers want to see if reducing routine surveillance affects quality of life and health outcomes.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
560 people
Ages
18 years and older
Study type
Observational

Who can take part

  • You are a woman aged 18 or older
  • You were diagnosed with breast cancer and completed curative (cancer-fighting) treatment
  • You are currently 24 months into your follow-up care with no signs of cancer returning
  • You have no physical signs or imaging evidence of cancer recurrence or spread
  • You live in the Republic of Ireland and plan to stay in the Irish healthcare system
  • You can speak, read, and write English well enough to complete a health questionnaire

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07616258Recruiting
Reducing follow-up visits after breast cancer treatment

This study tests whether some patients who finished curative breast cancer treatment can safely have fewer follow-up appointments and scans. Researchers want to see if less frequent monitoring is safe for patients without any signs of cancer returning.

Beaumont, Dublin
NCT05658172Recruiting
Less vs more frequent follow-up after early breast cancer

This trial compares standard follow-up visits versus more intensive follow-up for people with early breast cancer after their main treatment. The goal is to see whether closer monitoring finds problems earlier or improves outcomes.

Ulm
NCT07357311Recruiting
Screening for Fear of Cancer Recurrence

This study aims to help people with breast or lung cancer who worry about their cancer coming back. You will answer questionnaires about your fears, so the care team can better support you.

Paris
NCT05708235Recruiting· Phase 2
Blood test monitoring for early breast cancer recurrence

This trial uses a blood test to look for tiny bits of tumor DNA after treatment. If found, participants receive new drug combinations to try to prevent cancer from returning.

A Coruña
NCT05587777Recruiting
Tracking chronic conditions during standard breast cancer treatment

This study monitors health problems that can happen over time in people with breast cancer while they receive usual treatments like hormone therapy, chemotherapy, and/or radiation. It may help researchers understand which extra symptoms or complications show up and when, to improve care and follow-up.

Stavanger
NCT05975437Enrolling by invitation
Personalized follow-up care after breast cancer treatment

This trial tests whether a personalized follow-up plan after breast cancer surgery (instead of a fixed schedule) can improve care and support after treatment. It may help people know what follow-up is best for them as they move into survivorship.

Apeldoorn, Gelderland

Hear when a new Breast cancer trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.